Research uses AHK-Cu to study copper-tripeptide effects on tissue, with one in-vitro study examining its effect on human hair-follicle cells (Learn more). This work sits alongside broader copper-peptide research into dermal and wound-repair biology, connecting to related compounds such as GHK-Cu.
Inside the human hair-follicle study
The paper that put AHK-Cu on the research map came from the Department of Dermatology at Seoul National University, published in Archives of Pharmacal Research in 2007. Pyo and colleagues worked with two complementary systems. First, they took isolated human hair follicles and kept them growing ex vivo, so the whole mini-organ could be measured as it lengthened. Second, they cultured dermal papilla cells, the specialised cells at the base of each follicle, to see what was happening at the cellular level.
In both systems AHK-Cu produced a response at strikingly low concentrations, between 10-12 and 10-9 M, which is the picomolar to nanomolar range. Follicles elongated further, and dermal papilla cells proliferated more, than in untreated controls. That combination of whole-follicle data and cell-culture data is what makes the study so useful as a starting point: it links an effect on the organ to a measurable change in the cells that drive it. The full abstract is available on PubMed.
Dermal papilla cells and the survival signals
Dermal papilla cells are specialised fibroblasts clustered at the bottom of the follicle, and they act as its signalling centre, guiding how the follicle forms and how long it keeps growing. Because the growth phase ends when follicle cells start to die off in an orderly, programmed way, the balance between cell survival and cell death is a central question in hair biology.
That is exactly where the Seoul team looked next. In dermal papilla cells exposed to AHK-Cu at 10-9 M, the ratio of Bcl-2 (a protein that protects cells from programmed death) to Bax (a protein that promotes it) went up. At the same time, the cleaved, active forms of caspase-3 and PARP, two hallmark markers of a cell committing to programmed death, went down. A flow-cytometry count of dying cells pointed the same way, although that particular change did not reach statistical significance. The authors proposed that AHK-Cu supports follicle growth through two routes at once: more dermal papilla cells dividing, and fewer of them being lost.
One amino acid swap, a distinct copper complex
AHK-Cu is built from L-alanine, L-histidine and L-lysine, with a copper(II) ion held by the peptide. The histidine in second position is the key to that grip. Chemists file AHK under the “Xxx-His” family of copper-binding peptides: a free amino group at the front, then histidine. In that family the metal is gripped at three points supplied by the peptide itself, namely the N-terminal amine, the neighbouring amide link and the imidazole ring of histidine, while the remaining corner of the copper’s binding plane stays open to the surrounding solution.
The alanine at the front is what sets AHK-Cu apart. Its small methyl side chain makes the molecule slightly larger and less polar at the N-terminus than its better-known glycine-containing cousin, giving researchers a closely matched but separate copper peptide to work with. The Ala-His-Lys sequence also has an interesting natural echo: it forms residues two to four of Asp-Ala-His-Lys, the N-terminal copper-binding site of human serum albumin.
Fibroblasts, growth factors and the dermal matrix
Hair is only part of the AHK-Cu story. In framing their work, Pyo and colleagues noted earlier findings that tripeptide-copper complexes stimulate the proliferation of dermal fibroblasts, raise their output of vascular endothelial growth factor (VEGF) and reduce their secretion of transforming growth factor-beta1 (TGF-β1). Those three readouts matter in skin research because fibroblasts lay down collagen, VEGF drives new blood-vessel growth, and TGF-β1 is a master regulator of scarring and matrix build-up.
Copper itself is a working part of the dermal matrix too. Lysyl oxidase, the enzyme that cross-links collagen and elastin fibres so they gain strength, depends on copper to function. That is why copper peptides are studied in tissue-remodelling and wound-repair models, and why AHK-Cu is often designed into experiments alongside repair-focused peptides such as BPC-157 and TB-500, which bring cell-migration and vascular readouts to the same model.
